Objective: To study the anxiolytic-like activity of NR-ANX-C, a polyherbal product, in rats Materials and Methods: Inbred, male, Wistar albino rats weighing between 150 and 180 g were used. The standard anxiolytic, diazepam (0.5 mg and 1 mg/kg), and the test drug, NR-ANX-C powder (5, 10 and 20 mg/kg), were dissolved/suspended in 1% gum Department of Pharmacology, acacia solution and administered orally. In acute study the vehicle and the drugs were Kasturba Medical College, given sixty minutes prior to the experiment, while in the chronic study they were given Mangalore-575 001, twice daily for 10 days with the last dose one hour prior to the experiments (elevated plus Karnataka. India maze and light and dark box). time spent and the number of rears in bright chamber and decreased the duration of gopalakrishnahn@yahoo.co.in immobility. At lower doses (5 and 10 mg/kg), the test compound increased the number of entries into bright chamber. Locomotor activity in the open field test was not affected at all by the doses tested in acute study. On repeated administration, however, the test drug increased the locomotor activity. These changes are similar to those induced by the standard anxiolytic diazepam. Conclusion: NR-ANX-C exhibited anxiolytic-like activity comparable to that of diazepam.
Introduction
was undertaken to evaluate the effects of this polyherbal preparation on anxiety-like behaviour in rats. Two Anxiety is a normal emotional behaviour. When it is severe pharmacologically validated experimental models, elevated and/or chronic, however, it becomes pathological and can plus maze [2] and light and dark box, [3] were employed. precipitate or aggravate cardiovascular and psychiatric Materials and Methods disorders. Although many drugs are available in allopathic medicine to treat anxiety disorders, they produce various Animals systemic side effects or exhibit tolerance upon chronic use.
Male, Wistar albino rats weighing 150 to 180 g (90 to 110 In ayurvedic medicine, many plant products have been days old) were used for this study. They were housed in clean, claimed to be free from side effects and less toxic than clear, polypropylene cages in groups of four and maintained at synthetic drugs.
[1] NR-ANX-C, a polyherbal product containing 24±2 0 C with 12 h light and dark cycle. They had free access aqueous extracts of Withania somnifera and shilajit and to food and water. Experiments were conducted between 9:00 alcoholic extracts of Camellia sinensis and Ocimum sanctum to14:00 h. Each rat was used only once. provided by Natural Remedies, Bangalore, reportedly has Drugs antianxiety and antidepressant properties. Experimental and
The standard anxiolytic drug, diazepam and the test drug, clinical evidence are, however, lacking. Therefore, this study a dry powder of NR-ANX-C, (containing alcoholic extracts of Ocimum sanctum, Camellia sinensis and aqueous extracts of Withania somnifera and Shilajit, provided by Natural Remedies, Bangalore, India) were suspended in 1% gum acacia solution. Each drug solution was prepared freshly just before the administration. Drugs and vehicles were administered orally. The doses of each drug were selected on the basis of preliminary effects on muscle tone and locomotor activity. Three doses of NR-ANX-C that did not affect these parameters were used. Locomotor activity was assessed with open field test. [4] Concurrent control group of animals received appropriate volume of vehicle, 1% gum acacia solution. Drugs, dosage and number of animals used per treatment are shown in Tables 1 to 6 .
In acute study, drugs/vehicle were administered 60 min prior to experiment. In chronic study they were administered once daily for 10 days and the last dose was given on the 10 th day, 60 min prior to experiment.
Apparatus
Elevated plus maze [2] The wooden maze consisted of two open arms (length 50 cm X breadth 10 cm) and two closed arms of the same size (height 40 cm). The arms of the same type were opposite to each other, with a central square of 10 cm. The maze was elevated to a height of 50 cm above the floor. Light and dark box [3] The apparatus consisted of an open top wooden box. Two distinct chambers, a black chamber (20 X 30 X 35 cm) painted black and illuminated with dimmed red light and a bright chamber (30 X 30 X 35 cm) painted white and brightly illuminated with 100 W white light source, were located 17 cm above the box. The two chambers were connected through a small open doorway (7.5 X 5 cm) situated on the floor level at the centre of the partition. Open field [4] The apparatus consisted of a large rectangular box (100 X 80 cm) with 60 cm high walls. The floor was made of wire mesh and divided into twenty-five squares (outer 16 and central 9). The box was illuminated with 100 W bulb placed 60 cm above the centre of the field.
Behavioural assessment
Each animal was tested initially in plus maze and, then, in bright and dark arena paradigm in a single setting. In acute study 60 min after and in chronic study 60 min after the last dose on the 10 th day of drug or vehicle administration, each animal was placed in the centre square of the plus maze, facing one of the open arms. The number of entries into and the time spent in open and closed arms and the number of rears in each arm in a five-minute period was noted.
Following the elevated plus maze test, the animal was placed at the centre of the brightly lit arena in the light and dark box. The number of entries into and the time spent in the bright arena, the number of rears in the bright and dark arenas and the duration of immobility were noted.
Following each trial, the apparatus were cleaned to mask the odour left by the animal in the previous experiment. Hand operated counters and stop watches were used to score the behaviour of animals.
In the open field test each animal was placed in one of the peripheral corner squares of the box and the number of peripheral and central squares crossed, the time spent in central squares and the number of rears were observed for a five-minute period.
Statistical analysis
The data were analysed by one-way ANOVA with drug treatment as the independent factor. Post-hoc comparisons were performed by applying Dunnett's test. P<0.05 was considered statistically significant.
Results

Locomotor activity -Open field test
In the open field test, with acute drug treatment both the standard and the test drug did not increase the total number of squares crossed. [ Table 1 ] NR-ANX-C at the highest dose (20 mg/kg), however, increased both the number of inner squares crossed and the time spent in them. Diazepam (1 mg/ kg) increased only the time spent in inner squares without any significant change in crossing of inner squares.
In the chronic study, both diazepam (0.5 mg/kg) and NR ANX-C (5 and 10 mg/kg) not only increased the total number of squares (both peripheral and inner) crossed, but also the time spent in inner squares and the rears. At the highest dose (20 mg/kg), however, the test drug failed to alter any of the parameters studied. [ Table 2 Table 4 ] b. Light and dark box Acute Diazepam treated rats significantly increased the time spent (0.5 mg/kg) and the rears (0.5 and 1 mg/kg) in light arena and decreased the duration of immobility (0.5 mg/kg). At both the doses (0.5 and 1 mg/kg), however, it did not alter the Table 5 Effects of NR-ANX-C on behaviour of rats in bright and dark arena paradigm (acute study) Table 6 Effects of NR-ANX-C on behaviour of rats in bright and dark arena paradigm (acute study) number of entries into bright chamber to any significant dose (20 mg/kg). Increase in the number of entries into light extent. NR-ANX-C treated rats showed a significant increase chamber was not significant. [ Table 5 ] in the time spent (10 and 20 mg/kg) in light arena, while rearing Chronic (20 mg/kg) was increased in bright arena and dark arena. The
Repeated administration of diazepam (0.5 mg/kg) test drug reduced the duration of immobility at the highest significantly increased the time spent and the rears in light arena and decreased the duration of immobility. It did not, however, alter the number of entries into light chamber to any significant extent. NR-ANX-C, on repeated administration, increased the number of entries (5 and 10 mg/kg), time spent (5, 10 and 20 mg/kg) and rears in light as well as in dark chambers (5, 10 and 20 mg/kg). It decreased the duration of immobility at all the doses (5, 10 and 20 mg/kg) tested.
[ Table 6 ]
Discussion
The two experimental models of anxiety, elevated plus maze and bright and dark arena, are based on the assumption that unfamiliar, non-protective and brightly lit environmental stress provokes inhibition of normal behaviour. This normal behavioural inhibition is further augmented in the presence of fear or anxiety like state.
In In the light and dark box paradigm, the brightly lit environment is a noxious environment stressor that inhibits the exploratory behaviour of rodents. Reduction in the number of entries, time spent and rearing behaviour in the light chamber are regarded as markers of anxiety. [3] Rearing reflects an exploratory tendency [5] of the animal that can be reduced due to a high level of fear.
In the present study, rats that received acute as well as chronic diazepam showed a significant increase in the time spent and the rears in open arms and the percentile ratio of open arms. They showed a decrease, however, in the time spent in closed arms of elevated plus maze. They also showed an increase in the time spent and the rears in bright arena and a decrease in the duration of immobility in the light and dark arena paradigm. All these suggest decreased fear, an increased exploratory behaviour and the behavioural disinhbitory effect of the standard anxiolytic. The test compound, NR-ANX-C, increased the number of entries, time spent and rearing in open arms and also increased the percentile ratio of open arm to total arm entries in the elevated plus maze paradigm. In light and dark paradigm, the test drug significantly increased the time spent in light arena, rears in both light and dark arena and transition between chambers. All these behavioural changes in both paradigms are suggestive of decreased fear, decreased aversion to bright light and increased exploratory behaviour of the animal. These behavioural changes produced by the test compound NR ANX-C were comparable to those produced by diazepam.
The open field paradigm is used mainly to assess the locomotor activity of animals. In acute study, there was no significant change in the total number of squares crossed. This indicated the lack of effect of both the test and the standard drug on general motor activity. On repeated administration, however, the locomotor activity was increased as indicated by the enhanced peripheral, central and total number squares crossed. In addition, increased rearing, number of inner squares crossed and time spent in them reflect enhanced exploratory activity and reduced fear. [6] Withania somnifera, one of the constituents of NR-ANX-C, possesses antistress, adaptogenic and immunomodulatory properties, [7] with GABA mimetic activity. [8, 9] Probably this antistress property contributes to the anxiolytic effect of NR ANX-C. In addition, it has also been reported that the extract of Withania somnifera root and its bioactive compounds reduce the enhanced brain levels of tribulin, 5HT and corticotrophin, which are linked with anxiety state. [8] [9] [10] [11] Both Withania somnifera and Ocimum sanctum possess antistressor, adaptogenic, immunomodulatory and antioxidant properties. Ocimum sanctum is shown to have cortisol sparing, immunostimulant and antioxidant activities. This cortisol sparing immunomodulatory activity of Ocimum sanctum may also contribute to the behavioural disinhbitory activity. [12] [13] [14] Camellia sinensis, green tea, contains methyl xanthines (caffeine, theophylline), polyphenols and ascorbic acid. Methyl xanthines are central nervous system stimulants and have adenosine antagonistic activity. Adenosine agonists and antagonists produce anxiogenic and anxiolytic effects, respectively, in experimental animals. [15] Therefore, the role of methylxanthines of Camellia sinensis in the overall anxiolytic activity of NR-ANX-C cannot be explained.
Shilajit is considered useful in treating anxiety and stress. Evidence suggests that Shilajit reduces the turnover of serotonin. [16] Several studies have indicated that drugs, which increase or decrease the central serotonin concentration, are known to enhance or reduce the anxiety behaviour in animals, [17] [18] [19] [20] [21] respectively . Although the polyherbal product, NR-ANX-C, has shown anxiolytic-like effect, it is difficult to point out which constituent is responsible for the same. Ayurvedic treatises claim that drugs should not be used alone and should be used in combination. Drug combination ensures synergism and helps to overcome the side effects of the other drug. [22] This may be true for NR-ANX-C also, as this contains Withania somnifera extract that has sedative property. [8] This sedative effect is ameliorated by bioactive of Camellia sinensis that has a stimulant effect. [23] As the test drug possesses anxiolytic-like effect similar to that of diazepam, it can be further studied to determine its possible use in human beings.
